Axxcess Wealth Management LLC Acquires 117 Shares of Colgate-Palmolive (NYSE:CL)

Axxcess Wealth Management LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.3% in the fourth quarter, Holdings Channel reports. The firm owned 38,786 shares of the company’s stock after acquiring an additional 117 shares during the period. Axxcess Wealth Management LLC’s holdings in Colgate-Palmolive were worth $3,526,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $32,000. Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive during the 4th quarter worth $32,000. Finally, Wintrust Investments LLC bought a new stake in Colgate-Palmolive during the 4th quarter valued at $33,000. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CL. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Friday, March 14th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $89.45 on Wednesday. The business has a fifty day moving average of $89.13 and a 200 day moving average of $94.44. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market capitalization of $72.59 billion, a price-to-earnings ratio of 25.41, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business earned $0.87 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.